Related Experiment Video
Updated: May 13, 2025
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
506
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen1, Dhanshree Vikrant Konde1, Safal Kumar Paikray2
1Department of Biotechnology and Genetics, School of Sciences, Jain (Deemed-to-be-University), Bengaluru 560027, Karnataka, India.
Exploration of Targeted Anti-Tumor Therapy
|April 15, 2025
Summary
Nanotechnology enhances cancer immunotherapy by overcoming patient response variability and tumor microenvironment challenges. Nanomedicines show promise in activating immune responses and improving cancer treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Nanotechnology
Background:
- Cancer immunotherapy leverages the body's immune system but faces limitations like patient response heterogeneity and a suppressive tumor microenvironment.
- Nanotechnology offers novel solutions to enhance immunotherapy efficacy by addressing these challenges.
Purpose of the Study:
- To review advancements in nanotechnology for improving cancer immunotherapy.
- To explore nanomedicine applications, their mechanisms, and clinical potential.
Main Methods:
- Review of recent literature on nanotechnology applications in cancer immunotherapy.
- Analysis of nanomedicines including nanoparticle vaccines, liposomes, immune modulators, and gene delivery systems.
- Examination of preclinical and early clinical data on efficacy and safety.
Main Results:
- Nanotechnology-based approaches demonstrate multifaceted mechanisms to boost anti-tumor immunity and overcome immune suppression.
- Nanomedicines effectively activate immune responses, modulate tumor microenvironments, and target specific immune cells.
- Studies show improved survival rates, tumor regression, and immune activation with nano-immunotherapy.
Conclusions:
- Nanotechnology holds transformative potential for cancer immunotherapy, with promising results in areas like checkpoint inhibitor delivery and cancer vaccines.
- Challenges remain in manufacturing, off-target effects, and regulatory approval.
- Interdisciplinary collaboration is crucial for broader clinical adoption of nano-immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
01:30Cancer Vaccines
259
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
259
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
736
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
736